Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron

被引:0
|
作者
Hennig-Pauka, Isabel [1 ]
Ganter, Martin [2 ]
Bornhorn, Dirk [1 ]
Lyons, Wesley [3 ]
Marco, Enric [4 ]
Almond, Glen [5 ]
Schneider, Bettina [6 ]
Kreienbrock, Lothar [6 ]
Pedersen, Ken Steen [7 ,8 ]
机构
[1] Univ Vet Med Hannover, Field Stn Epidemiol, Buescheler Str 9, D-49456 Bakum, Germany
[2] Univ Vet Med Hannover, Clin Swine Small Ruminants Forens Med & Ambulatory, Bischofsholer Damm 15, D-30173 Hannover, Germany
[3] Pharmacosmos Inc, Watchung, NJ 07069 USA
[4] Marco Vetgrup SLP, C St Pauli Nola 6, Barcelona 08004, Spain
[5] North Carolina State Univ, Coll Vet Med, Raleigh, NC USA
[6] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Bunteweg 2, D-30559 Hannover, Germany
[7] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Gronnegardsvej 2, DK-1870 Frederiksberg C, Denmark
[8] O Vet AS, Koberupvej 33, DK-4700 Naestved, Denmark
关键词
Anaemia; Average daily weight gain; Birth weight; Haemoglobin; Packed cell volume; SUCKLING PIGLETS; BLOOD HEMOGLOBIN; DEFICIENCY; WEIGHT; SUPPLEMENTATION; ANEMIA; GROWTH; PERFORMANCE; HEMATOLOGY; INJECTION;
D O I
10.1186/s13028-024-00790-6
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
BackgroundPrevention of iron deficiency in suckling piglets by intramuscular injection of a standardized amount of iron dextran or gleptoferron in the first days of life can lead to over- or underdosage with respective health risks. Currently, combined iron products containing an active substance against coccidia are also used on farms. When using a combination product targeting two diseases, an adjustment of the necessary amount of iron to prevent anaemia in the frame of a farm-specific treatment protocol is not possible. The aim of this study was to test if iron dextran, which can be used in flexible volumes, is statistically non-inferior to a combinatory product, containing gleptoferron and toltrazuril. In addition, different administration schemes for iron dextran with respect to time point and dosage were compared on a conventional farm. Within each out of 17 litters eight healthy piglets were allocated to one of the four treatment groups on the second day of life: (1) 200 mg iron dextran, (2) 200 mg gleptoferron and 45 mg toltrazuril in combination, (3) 300 mg iron dextran, (4) 200 mg iron dextran and additional intramuscular administration of 200 mg iron dextran on day 11 of life. Pigs of groups 1, 3 and 4 received toltrazuril orally. Red blood cell measures were determined prior to treatment on day 2 of life and at weaning. Body weights were measured on day 2, 24, 74 and 160 of life.ResultsIron dextran was non-inferior compared to gleptoferron within a tolerance range of +/- 5 g haemoglobin/L. In total, treatment groups did not differ with respect to red blood cell parameters and average daily weight gain. The 50% pigs with intermediate birth weights profited from an additional iron dextran administration with respect to higher haemoglobin concentrations at weaning.ConclusionsIn this investigation gleptoferron and iron dextran appear equally appropriate for prevention of iron deficiency anaemia. Piglets of different birth weights might profit differently from an additional iron administration, so that usage of a product containing iron as a single substance is of advantage to allow a flexible adjustment of dosage during the suckling period.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients - the study design for a multi-centre prospective epidemiologic non-inferiority trial
    Meybohm, Patrick
    Fischer, Dania Patricia
    Geisen, Christof
    Mueller, Markus Matthias
    Weber, Christian Friedrich
    Herrmann, Eva
    Steffen, Bjoern
    Seifried, Erhard
    Zacharowski, Kai
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [22] Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients - the study design for a multi-centre prospective epidemiologic non-inferiority trial
    Patrick Meybohm
    Dania Patricia Fischer
    Christof Geisen
    Markus Matthias Miller
    Christian Friedrich Weber
    Eva Herrmann
    Bjirn Steffen
    Erhard Seifried
    Kai Zacharowski
    BMC Health Services Research, 14
  • [23] A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6-35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The Gambia
    Mohammed, Nuredin I.
    Wason, James
    Mendy, Thomas
    Nass, Stefan A.
    Ofordile, Ogochukwu
    Camara, Famalang
    Baldeh, Bakary
    Sanyang, Chilel
    Jallow, Amadou T.
    Hossain, Ilias
    Faria, Nuno
    Powell, Jonathan J.
    Prentice, Andrew M.
    Pereira, Dora I. A.
    ECLINICALMEDICINE, 2023, 56
  • [24] Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (Retacrit™) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis
    Thadhani, Ravi
    Guilatco, Ruffy
    Hymes, Jeffrey
    Maddux, Franklin W.
    Ahuja, Ajay
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (03) : 214 - 224
  • [25] Comparison of the Therapeutic Efficacy of a Fixed Low-Dose Combination of Cinnarizine and Dimenhydrinate with Betahistine in Vestibular Neuritis A Randomized, Double-Blind, Non-Inferiority Study
    Scholtz, Arne-Wulf
    Steindl, Raluca
    Burchardi, Nicole
    Bognar-Steinberg, Irene
    Baumann, Wolfgang
    CLINICAL DRUG INVESTIGATION, 2012, 32 (06) : 387 - 399
  • [26] Day-patient treatment after short inpatient care versus continued inpatient treatment in adolescents with anorexia nervosa (ANDI): a multicentre, randomised, open-label, non-inferiority trial
    Herpertz-Dahlmann, Beate
    Schwarte, Reinhild
    Krei, Melanie
    Egberts, Karin
    Warnke, Andreas
    Wewetzer, Christoph
    Pfeiffer, Ernst
    Fleischhaker, Christian
    Scherag, Andre
    Holtkamp, Kristian
    Hagenah, Ulrich
    Buehren, Katharina
    Konrad, Kerstin
    Schmidt, Ulrike
    Schade-Brittinger, Carmen
    Timmesfeld, Nina
    Dempfle, Astrid
    LANCET, 2014, 383 (9924) : 1222 - 1229
  • [27] Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
    Esu, Ekpereonne
    Berens-Riha, Nicole
    Pritsch, Michael
    Nwachuku, Nuria
    Loescher, Thomas
    Meremikwu, Martin
    MALARIA JOURNAL, 2018, 17
  • [28] Use of virtual reality to remotely train healthcare professionals in paediatric emergency tracheostomy skills: protocol for a multi-centre, non-inferiority educational interventional study with historical controls
    Abbas, Jonathan R.
    Younis, Noorulanne
    Johnstone, Emily
    Rajai, Azita
    Isba, Rachel
    Payton, Antony
    Mcgrath, Brendan A.
    Tolley, Neil
    Bruce, Iain A.
    BMC SURGERY, 2025, 25 (01)
  • [29] The Efficacy and Safety of GF101 and Its Antioxidant Effect on In Vitro Fertilization Outcomes: A Double-Blind, Non-Inferiority, Randomized, Controlled Trial with Coenzyme Q10
    Shin, So Yeon
    Yoon, Hye Kyung
    Kim, Jee Hyun
    Kim, Ji Hyang
    Park, Chan
    Choi, Dong Hee
    Yu, Young Dong
    Shin, Ji Eun
    Kwon, Hwang
    ANTIOXIDANTS, 2024, 13 (03)
  • [30] Comparison of the effect of intramuscular injection from two different sites on pain and fear in children: a randomized controlled study
    Tiryaki, Oznur
    Menekse, Dilek
    Ozdemir, Oner
    Cinar, Nursan
    Elmas, Bahri
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (11):